Sanjivani Parenteral Ltd. presented their performance report for Q3 FY25, showing a 25% increase in revenue year-over-year to Rs. 519.2 million and a 20.4% increase in PAT to Rs. 59.1 million.
AI Assistant
Sanjivani Paranteral Ltd
2025
Announcement
Find Answers
Ask about any part of the document to get insights, explanations, or key details.